Zymergen (ZY) Gross Profit Margin starting from the second quarter 2022 to second quarter 2021, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Zymergen Inc.  (NASDAQ: ZY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Zymergen's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZY Gross Profit Margin (Jun 30 2022)
Q2 		(Mar 31 2022)
Q1 		(Dec 31 2021)
Q4 		(Sep 30 2021)
Q3 		(Jun 30 2021)
Q2
Y / Y Revenue Change -55.26 %
Seq. Revenue Change -45.02 %
Revenue In Millions $2.63
Gross Profit Margin 75.82 %
Gross Profit Margin Total Ranking # 718
Gross Profit In Millions $2.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2022 Gross Profit Margin
Zymergen Inc. achieved Gross Profit of $2 millions compare to Gross Loss of $-7.66 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q2 of -45.02 % Zymergen Inc. managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 2 compare to Gross Loss of $-7.66 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 75.82 %, a new company high.


Observing second quarter 2022 results within Medical Laboratories industry 5 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 718.
Learn about Gross Margin
ZY's Gross Profit Margin second quarter 2022 Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 153
Overall # 702

Gross Profit Margin Statistics
High Average Low
75.82 % 75.82 % 75.82 %
(Jun 30 2022)  


ZY Gross Income Trends • More of ZY's Profitabilty Ratios • ZY Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ZY's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ZY's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ZY's Competitors
Gross Profit Margin Profit Margin for Zymergen's Suppliers
Gross Profit Margin Profit Margin for ZY's Customers

You may also want to know
ZY's Annual Growth Rates ZY's Profitability Ratios ZY's Asset Turnover Ratio ZY's Dividend Growth
ZY's Roe ZY's Valuation Ratios ZY's Financial Strength Ratios ZY's Gross Profit Growth
ZY's Roa ZY's Inventory Turnover Ratio ZY's Growth Rates ZY's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2022, within Medical Laboratories Industry Gross Profit MarginJun 30 2022 MRQ Gross ProfitJun 30 2022 MRQ Revenue
Incyte Corporation  94.44 %$ 860.761  Millions$ 911.397  Millions
Maxcyte inc   88.34 %$ 8.487  Millions$ 9.608  Millions
Inotiv Inc   80.03 %$ 138.189  Millions$ 172.666  Millions
Castle Biosciences Inc   77.94 %$ 27.152  Millions$ 34.838  Millions
Caredx Inc   77.39 %$ 62.404  Millions$ 80.634  Millions
Zymergen Inc.  75.82 %$ 1.997  Millions$ 2.634  Millions
U s Stem Cell Inc   74.52 %$ 0.018  Millions$ 0.025  Millions
Veracyte Inc   74.49 %$ 54.280  Millions$ 72.864  Millions
Exact Sciences Corporation  72.08 %$ 373.321  Millions$ 517.921  Millions
Nrc Health  63.11 %$ 23.534  Millions$ 37.292  Millions
Luna Innovations Inc  61.02 %$ 15.963  Millions$ 26.162  Millions
Ispecimen inc   57.25 %$ 1.339  Millions$ 2.339  Millions
Butterfly Network Inc   55.02 %$ 10.572  Millions$ 19.215  Millions
Hologic Inc  54.83 %$ 549.800  Millions$ 1,002.700  Millions
Somalogic Inc   53.54 %$ 7.573  Millions$ 14.144  Millions
Fulgent Genetics Inc   52.08 %$ 65.276  Millions$ 125.341  Millions
Charles River Laboratories International inc   46.29 %$ 450.508  Millions$ 973.131  Millions
Natera Inc   45.13 %$ 89.444  Millions$ 198.200  Millions
American Shared Hospital Services  41.48 %$ 2.088  Millions$ 5.034  Millions
Renalytix Plc  40.35 %$ 0.481  Millions$ 1.192  Millions
Ge Healthcare Technologies Inc   40.05 %$ 1,796.000  Millions$ 4,484.000  Millions
Labcorp Holdings Inc   38.41 %$ 1,122.700  Millions$ 2,923.000  Millions
Psychemedics Corporation  34.90 %$ 2.273  Millions$ 6.513  Millions
Quest Diagnostics Inc  34.33 %$ 842.000  Millions$ 2,453.000  Millions
Iqvia Holdings Inc   34.17 %$ 1,210.000  Millions$ 3,541.000  Millions
Capforce Inc   33.17 %$ 0.321  Millions$ 0.967  Millions
Medpace Holdings Inc   28.19 %$ 98.996  Millions$ 351.207  Millions
Science 37 Holdings Inc   28.19 %$ 5.433  Millions$ 19.275  Millions
Advanced Container Technologies Inc   28.03 %$ 0.207  Millions$ 0.739  Millions
Biocept Inc   24.39 %$ 2.588  Millions$ 10.611  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.